脳深部刺激装置の世界市場：現状分析・予測（2022年～2028年）

世界の深部脳刺激装置の市場規模は、予測期間中に約12％の著しい成長を遂げると予測されています。また、神経疾患の増加、先端技術の採用が、脳深部刺激装置市場の重要な成長促進要因です。

当レポートでは、世界の脳深部刺激装置市場について調査分析し、セグメント別・地域別の市場洞察、市場力学、市場動向、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提条件

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 脳深部刺激装置市場に対するCOVID-19の影響

第6章 脳深部刺激装置市場収益（2020年～2028年）

第7章 市場洞察：用途別

• 疼痛管理
• てんかん
• 本態性振戦
• 強迫性障害（OCD）
• パーキンソン病
• うつ
• ジストニア
• その他

第8章 市場洞察：エンドユーザー別

• 病院
• 神経科クリニック
• 外来手術センター
• 研究センター

第9章 市場洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他北米
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• その他の地域

第10章 脳深部刺激装置：市場力学

• 市場促進要因
• 市場課題
• 影響分析

第11章 脳深部刺激装置：市場機会

第12章 脳深部刺激装置：市場動向

第13章 需要サイド・供給サイドの分析

• 需要サイド分析
• 供給サイド分析

第14章 バリューチェーン分析

第15章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第16章 企業概要

• Abbott
• Boston Scientific Corporation
• Medtronic
• Aleva Neurotherapeutics
• Nexstim Oyj
• LivaNova PLC
• NeuroPace, Inc.
• Functional Neuromodulation Ltd.
• SceneRay Co., Ltd.
• Neuronetics

第17章 免責事項

The global deep brain stimulation devices market is expected to grow at a significant rate of around 12% during the forecast period. Deep brain stimulation (DBS) involves the application of a device called a neurostimulator, to deliver electrical signals to the areas of the brain that control movement, pain, mood, weight, obsessive-compulsive thoughts, and awakening from a coma. The rising occurrence of neurological diseases, along with the adoption of advanced technology are the important factors responsible for the growth of the deep brain stimulation devices market. Furthermore, frequent product launches also attribute to the surging demand for deep brain stimulation devices. For instance, Medtronic plc, the global leader in medical technology announced the U.S. Food and Drug Administration (FDA) approval for its SenSight™ Directional Lead System, which is the first U.S. implant used for deep brain stimulation (DBS) therapy.

Abbott; Boston Scientific Corporation; Medtronic; Aleva Neurotherapeutics; Nexstim Oyj; LivaNova PLC; NeuroPace, Inc.; Functional Neuromodulation Ltd.; SceneRay Co., Ltd.; and Neuronetics. Are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Application, epilepsy category to witness higher CAGR during the forecast period"

Based on the application, the market has been categorized into pain management, epilepsy, essential tremor, obsessive-compulsive disorder (OCD), Parkinson's disease, depression, dystonia, and others. Among them, the epilepsy segment is expected to grow at the highest CAGR in the market. The rising prevalence of epilepsy and the growing awareness about advanced treatment options are the important factors responsible for the segmental growth. For instance, according to WHO, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

"Amongst End-use, ambulatory surgical centers segment to grow with a significant CAGR during the forecast period"

Based on the end-use, the market has been categorized into hospitals, neurology clinics, ambulatory surgical centers, and research centers. Among them, the ambulatory surgical center's segment is expected to grow at a significant CAGR during the forecast period. The ASCs provide the point of care treatment, can offer low-cost treatment, and reduces waiting time in emergency cases. These factors are responsible for the segmental growth of ambulatory surgical centers.

"Asia Pacific to witness the fastest growth in the market"

For a better understanding of the market adoption of the deep brain stimulation devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as rising medical expenditure, increasing disposable income of people, along with favorable government initiatives attributes to the market growth of deep brain stimulation devices in the region. For instance, as per the world bank, the per capita healthcare expenditure of Japan accounted for USD 3988.36 in 2012, which reached USD 4587.03 in 2019.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at one glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The global Deep Brain Stimulation Devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Deep Brain Stimulation Devices Market
• 2.2. Research Methodology of the Deep Brain Stimulation Devices Market
• 2.3. Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE DEEP BRAIN STIMULATION DEVICES MARKET

6. DEEP BRAIN STIMULATION DEVICES MARKET REVENUE (USD BN), 2020-2028F

7. MARKET INSIGHTS BY APPLICATION

• 7.1. Pain management
• 7.2. Epilepsy
• 7.3. Essential tremor
• 7.4. Obsessive-compulsive disorder (OCD)
• 7.5. Parkinson's disease
• 7.6. Depression
• 7.7. Dystonia
• 7.8. Others

8. MARKET INSIGHTS BY END-USE

• 8.1. Hospitals
• 8.2. Neurology clinics
• 8.3. Ambulatory surgical centers
• 8.4. Research centers

9. MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10. DEEP BRAIN STIMULATION DEVICES MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11. DEEP BRAIN STIMULATION DEVICES MARKET OPPORTUNITIES

12. DEEP BRAIN STIMULATION DEVICES MARKET TRENDS

13. DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14. VALUE CHAIN ANALYSIS

15. COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16. COMPANY PROFILED

• 16.1. Abbott
• 16.2. Boston Scientific Corporation
• 16.3. Medtronic
• 16.4. Aleva Neurotherapeutics
• 16.5. Nexstim Oyj
• 16.6. LivaNova PLC
• 16.7. NeuroPace, Inc.
• 16.8. Functional Neuromodulation Ltd.
• 16.9. SceneRay Co., Ltd.
• 16.10. Neuronetics

17. DISCLAIMER